Harbor Capital Advisors, Inc. Invitae Corp Transaction History

Harbor Capital Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	SELL	$0.42 - $0.72 $2,232 - $3,827	-5,316 Reduced 2.37%	219,326 $138,000
Q3 2023 Oct 20, 2023	BUY	$0.6 - $1.53 $26,185 - $66,772	43,642 Added 24.11%	224,642 $134,000
Q2 2023 Jul 11, 2023	BUY	$1.05 - $1.63 $17,383 - $26,986	16,556 Added 10.07%	181,000 $204,000
Q1 2023 Apr 26, 2023	BUY	$1.2 - $2.73 $58,178 - $132,355	48,482 Added 41.81%	164,444 $221,000
Q4 2022 Jan 20, 2023	SELL	$1.71 - $3.61 $4,252 - $8,978	-2,487 Reduced 2.1%	115,962 $0

Q3 2022 Oct 28, 2022	BUY	$1.9 - $8.63 $27,608 - $125,402	14,531 Added 13.98%	118,449 $291,000
Q2 2022 Jul 26, 2022	BUY	$2.13 - $9.01 $221,345 - $936,301	103,918 New	103,918 $254,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.